FINWIRES · TerminalLIVE
FINWIRES

Aduro Clean Technologies社、HCTは「高パラフィン系」原油にも適用可能と発表

-- アデューロ・クリーン・テクノロジーズ(ACT.CN)は木曜日、同社の水素化化学分解技術(HCT)が「高パラフィン系」原油にも適用可能になったと発表した。 この進歩は、重質ビチューメンの高度化や廃プラスチックの化学リサイクルに続く、HCTの新たな応用分野となる可能性を秘めている。これにより、多様な炭化水素原料への技術適用範囲が拡大する。 アデューロは、この技術開発を保護するため、米国特許商標庁(USPTO)に継続特許出願(一部継続出願)を提出した。 パラフィン系原油は世界の原油生産量の20~33%を占めるが、輸送と処理の制約により、受け入れ可能な製油所が限られ、市場価値が低下している。しかし、これらの原料は、低硫黄・低金属含有量、高セタン価ディーゼル収率、潤滑油基油や流動接触分解(FCC)用途における優れた性能など、精製特性に優れていることがますます認識されつつある、と同社は声明で述べた。 「パラフィン系原油は広く生産され、本来的に価値が高いものの、過剰な取り扱いと処理要件によってその潜在能力が十分に活用されていないのが現状です。今回の拡張は、当社の技術の関連性と炭化水素バリューチェーン全体における潜在的な応用範囲を拡大するための、実践的な一歩と言えるでしょう。検証済みの新たな応用例が増えるごとに、HCTはプラットフォーム技術としての地位を強化し、当社の価値提案を高め、将来的に開拓できる潜在的な市場とパートナーの範囲を広げていきます」と、最高経営責任者(CEO)のオファー・ヴィカス氏は述べています。 アデューロ社の株価は、水曜日のカナダ証券取引所で1.12ドル高の16.39ドルで取引を終えました。

Related Articles

Research

Research Alert: CFRA Keeps Buy Opinion On Shares Of The Hartford Insurance Group, Inc.

CFRA, an independent research provider, has providedwith the following research alert. Analysts at CFRA have summarized their opinion as follows:We trim our 12-month target price by $8 to $155, valuing HIG shares at 11.3x our 2026 operating EPS estimate of $13.75 (cut by $0.45) and at 10.6x our 2027 EPS estimate of $14.65 (cut by $0.30), vs. the shares' one-year average forward multiple of 10.3x and peer average of 13x. Q1 EPS of $3.09 vs. $2.20 a year ago missed our $3.60 estimate and $3.39 consensus view. Operating revenue growth of 6.2% was in line with our 6%-10% forecast, amid 5.3% earned premium growth, 13% higher net investment income, and 7.9% fee revenue growth. Q1 written premium growth of 4% and full-year 2025 growth of 7% bode well for 2026 revenue trends as premiums are earned. Underwriting results improved significantly, with Personal Lines combined ratio improving to 87.7% from 106.1% and underlying combined ratio to 85.0% from 89.7%. Business Insurance combined ratio was stable at 94.8%. Weighing the Q1 EPS miss with HIG's decent top-line growth and discounted valuation to peers, we view the shares as undervalued.

$HIG
Research

Research Alert: CFRA Keeps Strong Buy Opinion On Shares Of Baker Hughes

CFRA, an independent research provider, has providedwith the following research alert. Analysts at CFRA have summarized their opinion as follows:We raise our 12-month target price by $14 to $82, reflecting a combination of our sum-of-the-parts (SOTP) and DCF models. For our SOTP model, we presume the oilfield services business (about 50% of BKR's franchise) to be valued at about 10x projected 2027 EBITDA (in line with major peers) and its industrial energy technology business (the other 50%) valued at 14x projected 2027 EBITDA (in line with the peer median). This blended approach, yielding a 12x multiple, implies a value of $73 per share. Meanwhile, our DCF model, using medium-term free cash flow growth of 5% per year, terminal growth of 2.5%, discounted at a WACC of 6.3%, yields intrinsic value of $91 per share. We cut our 2026 EPS estimate by $0.47 to $2.48, but we raise 2027's by $0.07 to $3.24. We acknowledge that the oilfield services business is likely to struggle in 2026 owing to the U.S.-Iran conflict, but the IET business appears quite robust and likely to be a source of both accelerating revenue growth and margins.

$BKR
Research

Research Alert: CFRA Maintains Hold Opinion In Shares Of Wab

CFRA, an independent research provider, has providedwith the following research alert. Analysts at CFRA have summarized their opinion as follows:We lift our 12-month target to $285 from $275 following WAB's Q1 earnings print, valuing shares at 24.2x our 2027 EPS outlook of $11.76 (revised from $11.46; 2026 EPS estimate up to $10.57 from $10.50), a slight premium to WAB's long-term historical multiple average given structural improvements in earnings quality. While we are cautious on signs of overcapacity in the freight market, an elevated order backlog (12-month sits at over $9 billion), internal initiatives to shore up margins, and potential synergies from M&A activity positions WAB to continue growing earnings at double-digit rates in 2026-2027, in our view. Despite tariff-related cost pressures, WAB has done a commendable job of defending margins via a mix of pricing, lean manufacturing, and pruning of lower-profit operations. Q1 results were mixed but overall positive, in our view. We maintain our Hold recommendation on shares.

$WAB